SCRI-CAR19x22v2 T Cell Product Demonstrates Bispecific Activity in B-ALL
Colleen Annesley(Unknown), Rebecca Gardner(Seattle Children's Hospital), Catherine Lindgren(Unknown), Michael C. Jensen(Seattle Children's Hospital), Julie R. Park(Seattle Children's Hospital), Ashley Wilson(Center for Infectious Disease Research), Qian Wu(Cancer Research Center), Wenjun Huang, Anant Vatsayan(Children's National), Amanda M. Li(BC Children's Hospital), Joshua D. Gustafson, Corinne Summers(Seattle Children's Hospital), Jodi Skiles(Indiana University School of Medicine), Stephanie Mgebroff(Bloodworks Northwest), Christopher Brown, Michael A. Pulsipher(Primary Children's Hospital)
Cited by 22
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
|New England Journal of Medicine|2016|1.8k